David Blue: Jenna, thanks for doing this interview. Can you start by sharing a bit about your career journey leading up to Genesis? Jenna Hollern: Certainly. I started my career at Stryker in Kalamazoo, MI, where I was part of their internal audit department. It was an enlightening experience, as I traveled to different manufacturing […]
From Genesis to HAPPE: An Interview with Jenna Hollern Read More »
We recently had the opportunity to meet with Andrew Iott, HAPPE Spine’s new President and CEO. HAPPE Spine announced in December of 2022 that Andrew Iott accepted an offer to become the President and CEO. Mr. Iott brings over twenty years of experience in medical device product development and commercialization, with extensive knowledge of the
Interview with Andrew Iott, the New President and CEO of HAPPE Spine Read More »
BONEZONE recently talked with Shoulder Innovations CCO David Blue and other orthopedic leaders to learn what’s driving growth in the shoulder replacement sector and how technologies will likely shape shoulder replacement implants over the coming years.
BONEZONE Features Shoulder Innovations Read More »
Recently, David Blue and Matt Ahearn presented on the latest with Shoulder Innovations at the 2022 LSI Emerging Medtech Summit.
Shoulder Innovations Presentation at 2022 LSI Conference Read More »
We’re excited to announce the addition of Len Tokish to the Genesis team as the new Vice President of Quality.
Genesis Announces New Vice President of Quality Read More »
Lincoln, Neb., and Pleasanton, Calif. – November 30, 2021 – Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, today announced it has raised $46 million in a Series C funding round. In addition to cultivate(MD) being a key investor in this Series C, Genesis Innovation Group also helped play
